US: 800.298.5699
Int'l: +1.240.747.3093
Latest Research by Email
Receive email alerts of new market research reports in your industry.
Sign Up Today >
|
|
|
Pharmaceuticals Market Research Reports
Find comprehensive market research and company reports on the Pharmaceuticals Industry. More specifically, find reports on the Dietary Supplements, AIDS, Allergies, Dentistry and Gastrointestinal Markets. Reports include data on market segmentation, size and growth in US, UK, Europe, Asia and global markets.
|
Biopharmaceuticals > 241
Biosimilars > 27
Biotechnology@ > 2813
Clinical Nutrition > 19
Country Overviews > 1038
Dietary Supplements > 506
Diseases & Conditions > 1039
AIDS, HIV & STDs > 119
Allergies@ > 185
Alzheimer's Disease > 55
Arthritis > 43
Asthma > 55
Autoimmune > 117
Blood Diseases > 45
Cancer@ > 659
Cardiovascular Disease@ > 324
Diabetes > 171
More...
Drug Delivery > 254
Drug Discovery > 857
|
Functional Foods & Beverages@ > 584
General Pharmaceuticals > 859
Generics Drugs > 344
Manufacturing, Packaging & Detailing > 1582
Over-the-Counter Drugs > 1107
Pharmaceuticals Company Reports > 4233
Pharmacy & Distribution > 184
Prescription Drugs > 1044
|
Pricing > 111
Regulation & Policy > 277
Research & Development > 760
Technology > 58
Therapeutic Area > 3331
Allergy/Immunology > 185
Behavioral Health > 162
Cardiovascular > 324
CNS/Neurology > 373
Dentistry/Oral > 107
Dermatology > 168
Endocrinology/Metabolics > 72
Gastrointestinal > 208
Gerontology/Aging > 48
Infectious Diseases > 219
More...
Vaccines > 283
Cancer Vaccines > 31
Pandemic Vaccines > 15
|
|
Title
|
Published
|
Price
|
|
Oncology Pipeline Database: 1-Year Subscription
By: La Merie S.L.
Subscription to La Merie’s proprietary Oncology Pipeline Database provides online access to more than 3,000 project entries in oncology. Each project is specified for its Target or Mechanism of Action, Product Category and R&D Phase.
|
more...
|
2/3/2010
|
$2,509.00
|
|
Drug Discovery in India and China - Gaining Momentum with Increasing Pressure on Cost Cutting
By: GBI Research
Drug Discovery in India and China - Gaining Momentum with Increasing Pressure on Cost Cutting Summary GBI Research, the leading business intelligence provider, has released its latest report, “Drug Discovery in India and China - Gaining Momentum
|
more...
|
2/1/2010
|
$3,500.00
|
|
Stroke, Cardiac & Pulmonary Rehabilitation
By: Apollo Managed Care Consultants
Clinical and review criteria guidelines for the post-acute evaluation and management of stroke and cardiac surgery or infarction rehabilitation including criteria for rehab admission, continued stay and discharge. Includes Apollo’s Coronary Artery/Peripheral Arterial Disease &
|
more...
Search inside this report
|
2/1/2010
|
$65.00
|
|
Major Depression and Bipolar Disorder - Evaluation and Management Guideline
By: Apollo Managed Care Consultants
Clinical guidelines for the evaluation and management of these 2 common disorders with extensive references and
|
more...
|
2/1/2010
|
$55.00
|
|
What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipeline
By: Kalorama Information
The global market for human vaccines has experienced strong growth in the past few years, and R&D departments at many pharmaceutical companies are working on new prophylactics, some of which may see near-term marketing.
|
more...
Search inside this report
|
2/1/2010
|
$4,200.00
|
|
Radio Frequency Identification (RFID) in Pharmaceuticals - Supply Chain Security Concerns Provide Impetus for RFID Adoption
By: GBI Research
Summary
GBI Research, the leading business intelligence provider, has released its latest research, “Radio Frequency Identification (RFID) in Pharmaceuticals -Supply Chain Security Concerns Provides Impetus for RFID Adoption.” It provides key data and analysis
|
more...
|
2/1/2010
|
$3,500.00
|
|
Pain -Evaluation & Management, 2nd Edition
By: Apollo Managed Care Consultants
The challenges of managing pain; classification of pain, pain measurement; health plan coverage for common tests, procedures, and treatment including complementary/alternative medicine, conventional drug therapies, opioids; patient consents, patient-provider contracts; provider credentialing; pain rehabilitation
|
more...
Search inside this report
|
2/1/2010
|
$75.00
|
|
Asthma - Evaluation and Management
By: Apollo Managed Care Consultants
Diagnosis, non-pharmaceutical and pharmaceutical management to improve the quality of care while reducing ER and hospital care. Authoritative references. Resources include disability evaluation/certification for asthma, patient education handouts, web
|
more...
|
2/1/2010
|
$55.00
|
|
Electrical and Magnetic Neurostimulation: Applications, Technologies, and Market Potential
By: Kalorama Information
Stimulation of muscles and nerves by the use of electrical stimulation, notably TENS and EMS, has long been part of pain management. But recent developments, such as implanted technologies and the small size/low cost
|
more...
Search inside this report
|
2/1/2010
|
$3,500.00
|
|
Obesity: Behavioral, Medical and Surgical Management, 2nd edition (updated 2010)
By: Apollo Managed Care Consultants
Obesity evaluation and multi-faceted management approaches to lead to health improvements through behavioral modification, balanced low-fat nutritional intake, daily exercise and, in severe obesity, surgical therapy considerations. Extensive medical literature references, resource
|
more...
Search inside this report
|
2/1/2010
|
$65.00
|
|
Hypertension + Heart Failure - evaluation and management guidelines:
By: Apollo Managed Care Consultants
Each guideline covers the clinical evaluation, non-pharmaceutical and pharmaceutical care management. Each has authoritative references, web links/other
|
more...
|
2/1/2010
|
$65.00
|
|
Alcohol/Substance Abuse & Dependency - Clinical Guideline, 2nd edition (2009 update)
By: Apollo Managed Care Consultants
Clinical guideline for screening, evaluation and management of alcohol and substance abuse disorders with extensive references and resources. Review criteria for out- or inpatient care - admission, continuing care and discharge are
|
more...
|
2/1/2010
|
$55.00
|
|
Orphan Drugs in Asia-Pacific: From Designation to Pricing, Funding & Market Access
By: JustPharmaReports.com
A major new report Orphan Drugs in Asia-Pacific: From designation to pricing, funding and market access focuses on five developed markets in the region: Japan, South Korea, Taiwan, Singapore and Australia. Each has passed specific
|
more...
Search inside this report
|
2/1/2010
|
$2,320.00
|
|
Brief Report: Interleukin-17 (IL-17R) and IL-17 Receptor Antagonists
By: La Merie S.L.
The present Brief Report about molecules targeting interleukin-17 (IL-17) or its receptor provides an assessment, competitor evaluation and detailed profiles of antibodies and other molecules in development. R&D projects of primarily antibodies targeting IL-17 or
|
more...
Search inside this report
|
2/1/2010
|
$697.00
|
|
Anxiety, Phobias & Panic Disorders
By: Apollo Managed Care Consultants
The diagnosis, evaluation and management (non-pharmaceutical and pharmaceutical) of this common cluster (includes PTSD and OCD guidelines) of disabling disorders are supported by references, web links, screening tools, other
|
more...
|
2/1/2010
|
$55.00
|
|
Worldwide Biotech - February 2010
By: Worldwide Videotex
Worldwide Biotech provides news and information on
biotechnology as an international industry, reporting on the
deals between U.S. biotechnology companies and international
pharmaceutical corporations. Monitors the emerging
European Community marketplace and the growing Japanese
|
more...
Search inside this report
|
2/1/2010
|
$25.00
|
|
Biomarkers, Tests and Trends for Drug R&D
By: Takeda Pacific
This report is about the world market for biomarkers and tests used for drug R&D. The study reviews and analyzes the market by examining biomarker related drug R&D spending, trends, major diseases, applications, M&As, alliances,
|
more...
|
2/1/2010
|
$2,400.00
|
|
Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs
By: GBI Research
Summary
GBI Research, the leading business intelligence provider, has released its latest research, “Biomarkers In Drug Discovery - Optimizing Drug Discovery Timeline and Costs”. The report provides an in-depth analysis of the potential applications
|
more...
|
2/1/2010
|
$3,500.00
|
|
Big Pharma's Key Lifecycle Management Strategies - Maximizing the Market Potential
By: GBI Research
Big Pharma's Key Lifecycle Management Strategies - Maximizing the Market Potential Summary GBI Research, the leading business intelligence provider, has released its latest research, “Big Pharma's Key Lifecycle Management Strategies: Maximizing the Market Potential.” It provides
|
more...
|
2/1/2010
|
$3,500.00
|
|
Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotechnology Clusters, Funding Characteristics and Regulatory Landscape
By: GBI Research
Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotechnology Clusters, Funding Characteristics and Regulatory Landscape Summary GBI Research, the leading business intelligence provider, has released its latest research, “Small and Medium Biopharmaceutical Enterprises in
|
more...
|
2/1/2010
|
$3,500.00
|
|
Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma
By: GBI Research
Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma Summary GBI Research, the leading business intelligence provider, has released its latest research “Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs
|
more...
|
2/1/2010
|
$3,500.00
|
|
Pharmaceutical Pricing and Reimbursement - Reference Pricing and Economic Evaluations Will Dominate Future Pricing and Reimbursement Strategies
By: GBI Research
Pharmaceutical Pricing and Reimbursement - Reference Pricing and Economic Evaluations Will Dominate Future Pricing and Reimbursement Strategies Summary GBI Research, the leading business intelligence provider, has released its latest research, “Pharmaceutical Pricing and Reimbursement - Reference Pricing
|
more...
|
2/1/2010
|
$3,500.00
|
|
Pharmaceutical Pricing, Reimbursement, and Market Access News in the Fourth Quarter of 2009
By: Decision Resources
Introduction:
The fourth quarter of 2009 left drug manufacturers with many unanswered questions that will have a major
bearing on the future direction of the pharmaceutical industry. The steady progress of healthcare reform legislation
in
|
more...
|
1/29/2010
|
$2,300.00
|
|
The Pharmaceutical Market: Italy
By: Espicom Healthcare Intelligence
Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section
|
more...
Search inside this report
|
1/27/2010
|
$1,130.00
|
|
The Pharmaceutical Market: Spain
By: Espicom Healthcare Intelligence
Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section
|
more...
Search inside this report
|
1/27/2010
|
$1,130.00
|
|
Title
|
Published
|
Price
|
|
|
(0 items)
